COLL Collegium Pharmaceutical
- 31.710
- -0.170-0.53%
Collegium Pharmaceutical News
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Kuhlmann Shirley R.
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Tupper Colleen
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Dreyer Scott
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director SANTINI GINO
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Melincoff Gwen A
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director McFarlane Neil F.
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Freund John Gordon
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Fallon John A.
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Balice-Gordon Rita J.
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Heffernan Michael Thomas
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director BOHLIN GAREN G
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Smith Thomas B
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Dreyer Scott
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Smith Thomas B
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Dreyer Scott
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Kuhlmann Shirley R.
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Ciaffoni Joseph
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Tupper Colleen
Collegium Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eventide Asset Management, LLC(8.07%),Finny Kuruvilla, M.D. Ph. D.(8.07%), etc.
Collegium Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.09%)
Analysis
Price Target
No Data
